APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

PET Radiopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PET Radiopharmaceuticals Industry Growth and Trends Forecast to 2032

Report ID 174024330119 December 2025102 pages

Choose your research edition.

Industry ResearchPET Radiopharmaceuticals Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal PET Radiopharmaceuticals Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal PET Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PET Radiopharmaceuticals Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal PET Radiopharmaceuticals Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global PET Radiopharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PET Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PET Radiopharmaceuticals include Cardinal Health Inc. (U.S.), Bayer AG (Germany), Nordion, Inc. (Canada), Mallinckrodt plc (Ireland), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), GE Healthcare (U.K.), Eczacibasi-Monrol Nuclear Products (Turkey) and Bracco Imaging S.p.A (Italy), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PET Radiopharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PET Radiopharmaceuticals market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PET Radiopharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PET Radiopharmaceuticals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PET Radiopharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PET Radiopharmaceuticals Market by Company

Cardinal Health Inc. (U.S.)

Bayer AG (Germany)

Nordion, Inc. (Canada)

Mallinckrodt plc (Ireland)

Lantheus Medical Imaging, Inc. (U.S.)

IBA Molecular Imaging (Belgium)

GE Healthcare (U.K.)

Eczacibasi-Monrol Nuclear Products (Turkey)

Bracco Imaging S.p.A (Italy)

Advanced Accelerator Applications S.A. (France)

PET Radiopharmaceuticals Segment by Type

F-18

Ru-82

Others

PET Radiopharmaceuticals Segment by Application

Neurology

Cardiology

Oncology

Others

PET Radiopharmaceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PET Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PET Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PET Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PET Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PET Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of F-18 Table 2. Major Company of Ru-82 Table 3. Major Company of Others Table 4. Global PET Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 6. Global PET Radiopharmaceuticals Sales Market Share in Volume by Type (2021-2026) Table 7. Global PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 8. Global PET Radiopharmaceuticals Sales Market Share in Value by Type (2021-2026) Table 9. Global PET Radiopharmaceuticals Price by Type (2021-2026) & (US$/Unit) Table 10. Global PET Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 11. Global PET Radiopharmaceuticals Sales Market Share in Volume by Type (2027-2032) Table 12. Global PET Radiopharmaceuticals Sales by Type (2027-2032) & (US$ Million) Table 13. Global PET Radiopharmaceuticals Sales Market Share in Value by Type (2027-2032) Table 14. Global PET Radiopharmaceuticals Price by Type (2027-2032) & (US$/Unit) Table 15. North America PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 16. North America PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 17. Europe PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 18. Europe PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 22. Latin America PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa PET Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa PET Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 25. PET Radiopharmaceuticals Industry Trends Table 26. PET Radiopharmaceuticals Industry Drivers Table 27. PET Radiopharmaceuticals Industry Opportunities and Challenges Table 28. PET Radiopharmaceuticals Industry Restraints Table 29. Global PET Radiopharmaceuticals Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global PET Radiopharmaceuticals Revenue Market Share by Company (2021-2026) Table 31. Global PET Radiopharmaceuticals Sales by Company (2021-2026) & (K Units) Table 32. Global PET Radiopharmaceuticals Sales Share by Company (2021-2026) Table 33. Global PET Radiopharmaceuticals Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global PET Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global PET Radiopharmaceuticals Major Company Production Sites and Headquarters Table 36. Global PET Radiopharmaceuticals Company, Product Type & Application Table 37. Global PET Radiopharmaceuticals Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global PET Radiopharmaceuticals Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global PET Radiopharmaceuticals Sales by Region (2021-2026) & (K Units) Table 42. Global PET Radiopharmaceuticals Sales Market Share in Volume by Region (2021-2026) Table 43. Global PET Radiopharmaceuticals Sales by Region (2021-2026) & (US$ Million) Table 44. Global PET Radiopharmaceuticals Sales Market Share in Value by Region (2021-2026) Table 45. Global PET Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global PET Radiopharmaceuticals Sales by Region (2027-2032) & (K Units) Table 47. Global PET Radiopharmaceuticals Sales Market Share in Volume by Region (2027-2032) Table 48. Global PET Radiopharmaceuticals Sales by Region (2027-2032) & (US$ Million) Table 49. Global PET Radiopharmaceuticals Sales Market Share in Value by Region (2027-2032) Table 50. Global PET Radiopharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global PET Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 53. Global PET Radiopharmaceuticals Sales Market Share in Volume by Application (2021-2026) Table 54. Global PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 55. Global PET Radiopharmaceuticals Sales Market Share in Value by Application (2021-2026) Table 56. Global PET Radiopharmaceuticals Price by Application (2021-2026) & (US$/Unit) Table 57. Global PET Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 58. Global PET Radiopharmaceuticals Sales Market Share in Volume by Application (2027-2032) Table 59. Global PET Radiopharmaceuticals Sales by Application (2027-2032) & (US$ Million) Table 60. Global PET Radiopharmaceuticals Sales Market Share in Value by Application (2027-2032) Table 61. Global PET Radiopharmaceuticals Price by Application (2027-2032) & (US$/Unit) Table 62. North America PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 63. North America PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 64. Europe PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 65. Europe PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 69. Latin America PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa PET Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 72. Cardinal Health Inc. (U.S.) Company Information Table 73. Cardinal Health Inc. (U.S.) Business Overview Table 74. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio Table 76. Cardinal Health Inc. (U.S.) Recent Development Table 77. Bayer AG (Germany) Company Information Table 78. Bayer AG (Germany) Business Overview Table 79. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio Table 81. Bayer AG (Germany) Recent Development Table 82. Nordion, Inc. (Canada) Company Information Table 83. Nordion, Inc. (Canada) Business Overview Table 84. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolio Table 86. Nordion, Inc. (Canada) Recent Development Table 87. Mallinckrodt plc (Ireland) Company Information Table 88. Mallinckrodt plc (Ireland) Business Overview Table 89. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio Table 91. Mallinckrodt plc (Ireland) Recent Development Table 92. Lantheus Medical Imaging, Inc. (U.S.) Company Information Table 93. Lantheus Medical Imaging, Inc. (U.S.) Business Overview Table 94. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio Table 96. Lantheus Medical Imaging, Inc. (U.S.) Recent Development Table 97. IBA Molecular Imaging (Belgium) Company Information Table 98. IBA Molecular Imaging (Belgium) Business Overview Table 99. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio Table 101. IBA Molecular Imaging (Belgium) Recent Development Table 102. GE Healthcare (U.K.) Company Information Table 103. GE Healthcare (U.K.) Business Overview Table 104. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolio Table 106. GE Healthcare (U.K.) Recent Development Table 107. Eczacibasi-Monrol Nuclear Products (Turkey) Company Information Table 108. Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview Table 109. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio Table 111. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development Table 112. Bracco Imaging S.p.A (Italy) Company Information Table 113. Bracco Imaging S.p.A (Italy) Business Overview Table 114. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolio Table 116. Bracco Imaging S.p.A (Italy) Recent Development Table 117. Advanced Accelerator Applications S.A. (France) Company Information Table 118. Advanced Accelerator Applications S.A. (France) Business Overview Table 119. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolio Table 121. Advanced Accelerator Applications S.A. (France) Recent Development Table 122. North America PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 124. North America PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 125. North America PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 127. North America PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 129. North America PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 130. North America PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 132. Europe PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 134. Europe PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 135. Europe PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 137. Europe PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 140. Europe PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 150. Asia-Pacific PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 152. Latin America PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 154. Latin America PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 155. Latin America PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 160. Latin America PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa PET Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa PET Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa PET Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa PET Radiopharmaceuticals Market Share by Country (2021-2026) Table 170. Middle East and Africa PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa PET Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. PET Radiopharmaceuticals Distributors List Table 175. PET Radiopharmaceuticals Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. PET Radiopharmaceuticals Image Figure 2. Global PET Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PET Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global PET Radiopharmaceuticals Sales (2021-2032) & (K Units) Figure 5. F-18 Image Figure 6. Global F-18 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Ru-82 Image Figure 8. Global Ru-82 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global PET Radiopharmaceuticals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global PET Radiopharmaceuticals Market Share by Type 2025 VS 2032 Figure 13. North America PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 14. North America PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 15. Europe PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 16. Europe PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 19. Latin America PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 20. Latin America PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa PET Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa PET Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 PET Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Neurology Image Figure 26. Global Neurology Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cardiology Image Figure 28. Global Cardiology Sales YoY Growth (2021-2032) & (K Units) Figure 29. Oncology Image Figure 30. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global PET Radiopharmaceuticals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global PET Radiopharmaceuticals Market Share by Application 2025 VS 2032 Figure 35. North America PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 36. North America PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 37. Europe PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 38. Europe PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 41. Latin America PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 42. Latin America PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa PET Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa PET Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 45. North America PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa PET Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa PET Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa PET Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa PET Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. PET Radiopharmaceuticals Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. PET Radiopharmaceuticals Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • F-18
  • Ru-82
  • Others
Applications
  • Neurology
  • Cardiology
  • Oncology
  • Others
Companies covered
  • Cardinal Health Inc. (U.S.)
  • Bayer AG (Germany)
  • Nordion, Inc. (Canada)
  • Mallinckrodt plc (Ireland)
  • Lantheus Medical Imaging, Inc. (U.S.)
  • IBA Molecular Imaging (Belgium)
  • GE Healthcare (U.K.)
  • Eczacibasi-Monrol Nuclear Products (Turkey)
  • Bracco Imaging S.p.A (Italy)
  • Advanced Accelerator Applications S.A. (France)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PET Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PET Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PET Radiopharmaceuticals Market by Type
  6. 1.3.1 F-18
  7. 1.3.2 Ru-82
  8. 1.3.3 Others
  9. 1.4 Global PET Radiopharmaceuticals Market Size by Type
  10. 1.4.1 Global PET Radiopharmaceuticals Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global PET Radiopharmaceuticals Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global PET Radiopharmaceuticals Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa PET Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PET Radiopharmaceuticals Industry Trends
  2. 2.2 PET Radiopharmaceuticals Industry Drivers
  3. 2.3 PET Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 PET Radiopharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PET Radiopharmaceuticals Revenue (2021-2026)
  2. 3.2 Global Top Players by PET Radiopharmaceuticals Sales (2021-2026)
  3. 3.3 Global Top Players by PET Radiopharmaceuticals Price (2021-2026)
  4. 3.4 Global PET Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PET Radiopharmaceuticals Major Company Production Sites & Headquarters
  6. 3.6 Global PET Radiopharmaceuticals Company, Product Type & Application
  7. 3.7 Global PET Radiopharmaceuticals Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PET Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PET Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PET Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 PET Radiopharmaceuticals Regional Status and Outlook
  1. 4.1 Global PET Radiopharmaceuticals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PET Radiopharmaceuticals Historic Market Size by Region
  3. 4.2.1 Global PET Radiopharmaceuticals Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PET Radiopharmaceuticals Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PET Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PET Radiopharmaceuticals Forecasted Market Size by Region
  7. 4.3.1 Global PET Radiopharmaceuticals Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PET Radiopharmaceuticals Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PET Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PET Radiopharmaceuticals by Application
  1. 5.1 PET Radiopharmaceuticals Market by Application
  2. 5.1.1 Neurology
  3. 5.1.2 Cardiology
  4. 5.1.3 Oncology
  5. 5.1.4 Others
  6. 5.2 Global PET Radiopharmaceuticals Market Size by Application
  7. 5.2.1 Global PET Radiopharmaceuticals Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global PET Radiopharmaceuticals Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global PET Radiopharmaceuticals Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa PET Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cardinal Health Inc. (U.S.)
  2. 6.1.1 Cardinal Health Inc. (U.S.) Company Information
  3. 6.1.2 Cardinal Health Inc. (U.S.) Business Overview
  4. 6.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio
  6. 6.1.5 Cardinal Health Inc. (U.S.) Recent Developments
  7. 6.2 Bayer AG (Germany)
  8. 6.2.1 Bayer AG (Germany) Company Information
  9. 6.2.2 Bayer AG (Germany) Business Overview
  10. 6.2.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio
  12. 6.2.5 Bayer AG (Germany) Recent Developments
  13. 6.3 Nordion, Inc. (Canada)
  14. 6.3.1 Nordion, Inc. (Canada) Company Information
  15. 6.3.2 Nordion, Inc. (Canada) Business Overview
  16. 6.3.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolio
  18. 6.3.5 Nordion, Inc. (Canada) Recent Developments
  19. 6.4 Mallinckrodt plc (Ireland)
  20. 6.4.1 Mallinckrodt plc (Ireland) Company Information
  21. 6.4.2 Mallinckrodt plc (Ireland) Business Overview
  22. 6.4.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio
  24. 6.4.5 Mallinckrodt plc (Ireland) Recent Developments
  25. 6.5 Lantheus Medical Imaging, Inc. (U.S.)
  26. 6.5.1 Lantheus Medical Imaging, Inc. (U.S.) Company Information
  27. 6.5.2 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
  28. 6.5.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio
  30. 6.5.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
  31. 6.6 IBA Molecular Imaging (Belgium)
  32. 6.6.1 IBA Molecular Imaging (Belgium) Company Information
  33. 6.6.2 IBA Molecular Imaging (Belgium) Business Overview
  34. 6.6.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio
  36. 6.6.5 IBA Molecular Imaging (Belgium) Recent Developments
  37. 6.7 GE Healthcare (U.K.)
  38. 6.7.1 GE Healthcare (U.K.) Company Information
  39. 6.7.2 GE Healthcare (U.K.) Business Overview
  40. 6.7.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolio
  42. 6.7.5 GE Healthcare (U.K.) Recent Developments
  43. 6.8 Eczacibasi-Monrol Nuclear Products (Turkey)
  44. 6.8.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Information
  45. 6.8.2 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
  46. 6.8.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio
  48. 6.8.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
  49. 6.9 Bracco Imaging S.p.A (Italy)
  50. 6.9.1 Bracco Imaging S.p.A (Italy) Company Information
  51. 6.9.2 Bracco Imaging S.p.A (Italy) Business Overview
  52. 6.9.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolio
  54. 6.9.5 Bracco Imaging S.p.A (Italy) Recent Developments
  55. 6.10 Advanced Accelerator Applications S.A. (France)
  56. 6.10.1 Advanced Accelerator Applications S.A. (France) Company Information
  57. 6.10.2 Advanced Accelerator Applications S.A. (France) Business Overview
  58. 6.10.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolio
  60. 6.10.5 Advanced Accelerator Applications S.A. (France) Recent Developments
7 North America by Country
  1. 7.1 North America PET Radiopharmaceuticals Sales by Country
  2. 7.1.1 North America PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 7.1.3 North America PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 7.2 North America PET Radiopharmaceuticals Market Size by Country
  6. 7.2.1 North America PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 7.2.3 North America PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PET Radiopharmaceuticals Sales by Country
  2. 8.1.1 Europe PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 8.1.3 Europe PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PET Radiopharmaceuticals Market Size by Country
  6. 8.2.1 Europe PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 8.2.3 Europe PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PET Radiopharmaceuticals Sales by Country
  2. 9.1.1 Asia-Pacific PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PET Radiopharmaceuticals Market Size by Country
  6. 9.2.1 Asia-Pacific PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PET Radiopharmaceuticals Sales by Country
  2. 10.1.1 South America PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 10.1.3 South America PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 10.2 South America PET Radiopharmaceuticals Market Size by Country
  6. 10.2.1 South America PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 10.2.3 South America PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country
  2. 11.1.1 Middle East and Africa PET Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PET Radiopharmaceuticals Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PET Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PET Radiopharmaceuticals Market Size by Country
  6. 11.2.1 Middle East and Africa PET Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PET Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PET Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PET Radiopharmaceuticals Value Chain Analysis
  2. 12.1.1 PET Radiopharmaceuticals Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PET Radiopharmaceuticals Production Mode & Process
  7. 12.2 PET Radiopharmaceuticals Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PET Radiopharmaceuticals Distributors
  10. 12.2.3 PET Radiopharmaceuticals Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst